磺胺苯 | 127-77-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 磺胺苯
• 中文别名: 4-氨基-N-苯基苯磺酰胺；苯磺胺
• 英文名称: p-aminobenzenesulphonanilide
• 英文别名: Sulfanilanilid；4-amino-N-phenylbenzenesulfonamide；Sulfabenz
• CAS: 127-77-5
• 化学式: C₁₂H₁₂N₂O₂S
• mdl: MFCD00233654
• 分子量: 248.305
• InChiKey: YBUXKQSCKVQATK-UHFFFAOYSA-N

物化性质

• 熔点：
  200°
• 密度：
  1.2701 (rough estimate)

计算性质

• 辛醇/水分配系数(LogP)：
  1.6
• 重原子数：
  17
• 可旋转键数：
  3
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  80.6
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2935009090
• WGK Germany：
  3
• 储存条件：
  室温

SDS

Material Safety Data Sheet

---

Section 1. Identification of the substance
Product Name: 4-Amino-n-phenyl-benzenesulfonamide
Synonyms:

---

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

---

Section 3. Composition/information on ingredients.
Ingredient name: 4-Amino-n-phenyl-benzenesulfonamide
CAS number: 127-77-5

---

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

---

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

---

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

---

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Store in closed vessels.
Storage:

---

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

---

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
No data
Melting point:
Flash point: No data
Density: No data
Molecular formula: C12H12N2O2S
Molecular weight: 248.3

---

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides, sulfur oxides.

---

Section 11. Toxicological information
No data.

---

Section 12. Ecological information
No data.

---

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

---

Section 14. Transportation information
Non-harzardous for air and ground transportation.

---

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.

---

SECTION 16 - ADDITIONAL INFORMATION
N/A

反应信息

• 作为反应物：
  描述：

  磺胺苯 在 sodium hypobromide 作用下， 生成 4,4'-azo-bis-benzenesulfonic acid dianilide
  参考文献：
  名称：

  Cingolani, Gazzetta Chimica Italiana, 1950, vol. 80, p. 376,383

  摘要：

  DOI：
• 作为产物：
  描述：

  对硝基苯磺酰氯 在 吡啶 、 palladium on activated charcoal 、 甲酸铵 作用下， 以 甲醇 为溶剂， 生成 磺胺苯
  参考文献：
  名称：

  脲基基团作为基于Ureido的阴离子受体中的电子吸收单元：增强的阴离子络合与去质子化。

  摘要：

  磺酰胺基团被用作吸电子基团，以增强基于尿素的受体的阴离子络合特征。合成并彻底测试了一系列磺酰胺基和尿素NH基团的酸度变化的受体。各个络合性质反映了给定分子中作为取代的函数的去质子/络合平衡。含有缀合sulphonamidic部分给电子基团的受体显示出朝向h时缔合常数2 PO 4 -和羧酸根阴离子，而那些含有吸电子基团倾向于sulphonamidic N中的去质子化ħ。可以通过在受体合成的早期阶段进行烷基化来避免去质子化问题，也可以将其用于插入合适的基团，从而使其锚定在各种底物上，从而形成更精细的受体结构。

  DOI：

  10.1002/cplu.202000326

文献信息

• [EN] 3-PHOSPHOGLYCERATE DEHYDROGENASE INHIBITORS AND USES THEREOF<br/>[FR] INHIBITEURS DE LA 3-PHOSPHOGLYCÉRATE DÉSHYDROGÉNASE ET LEURS UTILISATIONS
  申请人：RAZE THERAPEUTICS INC

  公开号：WO2017156181A1

  公开（公告）日：2017-09-14

  The present invention provides compounds, compositions thereof, and methods of using the same.

  本发明提供了化合物、其组合物以及使用这些化合物的方法。
• Synthesis, Reactions and Antimicrobial Activity of Thieno[2,3-<i>c</i>]pyridazine Derivatives
  作者：Fatma El Mariah

  DOI：10.3184/030823409x12508790019612

  日期：2009.10

  The reaction of N1-(un)substituted 4-aminosulfonamide with 6-chloropyridothienopyridazine (5) and 8-chloro-pyrimidothienopyridazine (14) gave 6-substituted aminopyridothienopyridazine (9) and 8-substituted amino-pyrimidothienopyridazine (16) respectively. All of the derivatives have been characterised by analytical and spectroscopic studies and also tested for their in vitro antibacterial and antifungal

  N1-(未)取代的4-氨基磺酰胺与6-氯吡啶并噻吩并哒嗪(5)和8-氯-嘧啶噻吩并哒嗪(14)的反应分别得到6-取代的氨基吡啶并噻吩并哒嗪(9)和8-取代的氨基-嘧啶噻吩并哒嗪(16)。所有衍生物都通过分析和光谱研究进行了表征，并且还测试了它们对多种微生物的体外抗菌和抗真菌活性。
• Design, synthesis and biological evaluation of GPR55 agonists
  作者：Lara Fakhouri、Christopher D. Cook、Mohammed H. Al-Huniti、Linda M. Console-Bram、Dow P. Hurst、Michael B.S. Spano、Daniel J. Nasrallah、Marc G. Caron、Larry S. Barak、Patricia H. Reggio、Mary E. Abood、Mitchell P. Croatt

  DOI：10.1016/j.bmc.2017.06.016

  日期：2017.8

  consisted of coupling a variety of p-aminophenyl sulfonamides to isothiocyanates to form acylthioureas. For the synthesis of a known naphthyl ethyl alcohol motif, route modification led to a shorter and more efficient process. The 22 analogues were analyzed for their ability to serve as agonists at GPR55 and valuable information for both ends of the molecule was ascertained.

  GPR55是一种G蛋白偶联受体，是缓解炎症和神经性疼痛并治疗骨质疏松症和癌症的诱人靶标。鉴定有效和选择性的配体将有助于进一步确立受体的特定生理作用和药理作用。为了实现这一目标，以模块方式合成了22种化合物的目标库，以获得结构活性关系信息。一般路线包括耦合各种p-氨基苯基磺酰胺形成异硫氰酸酯，形成酰基硫脲。为了合成已知的萘乙醇基序，路线修饰导致了更短且更有效的过程。分析了22种类似物在GPR55上充当激动剂的能力，并确定了该分子两端的有价值的信息。
• GLUTATHIONE-CHOLESTEROL DERIVATIVES AS BRAIN TARGETING AGENTS
  申请人：South Dakota Board of Regents

  公开号：US20200048305A1

  公开（公告）日：2020-02-13

  The present invention describes compositions containing cholesterol-linker-glutathione conjugates for targeting the brain by overcoming barrier entry to the CNS through the blood brain barrier (BBB), including micelle and liposome forms of such compositions. In addition, methods for treating subjects by administering such compositions are also disclosed.

  本发明描述了含有胆固醇-连接剂-谷胱甘肽共轭物的组合物，通过克服血脑屏障（BBB）进入中枢神经系统的屏障入口，包括这些组合物的胶束和脂质体形式。此外，还公开了通过给予这些组合物治疗受试者的方法。
• CONJUGATE-BASED ANTIFUNGAL AND ANTIBACTERIAL PRODRUGS
  申请人：Bapat Abhijit S.

  公开号：US20140364595A1

  公开（公告）日：2014-12-11

  The invention provides conjugate-based antifungal or antibacterial prodrugs formed by coupling at least one anti-fungal agent or antibacterial agent with at least one linker and/or carrier. The prodrugs are of formula: (i) (AFA) m -X-(L) n ; (ii) [(AFA) m′ -X] p -L; (iii) AFA-[X-(L) n′ ] q ; or (iv) (AFA) m″ -X, wherein: AFA is an antifungal agent or an antibacterial agent; L is a carrier; X is a linker; m ranges from 1 to 10; n ranges from 2 to 10; m′ is 1 to 10; p is 1 to 10; n′ is 1 to 10; and q is 1 to 10, provided that q′ and n are not both 1; and m″ is 1 to 10. The invention also provides nanoparticles comprising the conjugate-based prodrugs. Additionally, the invention also provides non-conjugated antifungal and antibacterial agents in the form of nanoparticles.

  该发明提供了由至少一种抗真菌剂或抗菌剂与至少一种连接剂和/或载体偶联形成的基于共轭的抗真菌或抗菌前药。这些前药的公式为：(i) (AFA) m -X-(L) n ; (ii) [(AFA) m′ -X] p -L; (iii) AFA-[X-(L) n′ ] q ; 或 (iv) (AFA) m″ -X，其中：AFA是抗真菌剂或抗菌剂；L是载体；X是连接剂；m范围从1到10；n范围从2到10；m′为1到10；p为1到10；n′为1到10；q为1到10，前提是q'和n不同时为1；m″为1到10。该发明还提供了包含基于共轭的前药的纳米粒子。此外，该发明还提供了以纳米粒子形式的非共轭抗真菌和抗菌剂。